Physician profile
Michael A Piskun
NPI 1104869684
$861.95
in general payments reported to CMS, 2019-2025
14 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $31.94 · 2021: $13.96 · 2022: $352 · 2023: $37.97 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $182.77 | 2019 | |
| Palette Life Sciences, INC. | $179.48 | 2022 | |
| Calyxo, INC. | $174.93 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $142.15 | 2022 | |
| Immunitybio, INC. | $30.47 | 2025 | |
| Novocure INC. | $20.47 | 2023 | Optune |
| Janssen Biotech, INC. | $19.84 | 2025 | Erleada |
| Eisai INC. | $18.48 | 2025 | |
| Glaxosmithkline, LLC. | $18.30 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.50 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.41 | 2022 | |
| Redhill Biopharma INC. | $13.96 | 2021 | |
| Medtronic USA, INC. | $13.64 | 2020 | |
| Abbvie INC. | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Piskun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.